Skip to the keys
Avihoffman

Three Stocks to Watch in 2026 and 2027 as Investors Weigh AI, Oil and Inflation

Debt & Credit [email protected] (Laura Miller) 658 reads

Tesco, Alphabet and AstraZeneca stand out to one analyst, while oil costs, persistent inflation and AI spending keep the market outlook uncertain.

Three Stocks to Watch in 2026 and 2027 as Investors Weigh AI, Oil and Inflation

Strong company profits are helping support share prices, but investors face a harder question: can earnings keep growing if borrowing and energy costs rise? Chris Beauchamp, chief market analyst at IG, sees that tension shaping markets through 2026 and into 2027. He highlights three companies across retail, technology and pharmaceuticals, while pointing to artificial intelligence, oil, inflation and earnings as the forces to watch.

These are an analyst’s stock selections, not a guarantee of performance. Each company has a different business and risk profile, and the broader market backdrop could affect all three.

Three companies on Beauchamp’s list

Tesco: cash generation and competition

Tesco (LON:TSCO) has maintained a strong position in UK supermarkets by competing on price and producing resilient earnings in a crowded sector. Beauchamp’s case rests on the combination of its established market presence, dependable cash generation and capacity to keep investing in the business.

He also points to the company’s increased share buybacks alongside capital expenditure. Buybacks return cash to shareholders by reducing the number of shares in circulation, while capital spending can support operations and growth. The balance between those uses matters: investors will want to see the business continue to fund its needs while delivering the shareholder returns Beauchamp highlights.

For investors looking for exposure to a large retailer with defensive qualities, Tesco may merit attention. Its performance still depends on how well it competes on price and manages the pressures facing supermarkets.

Alphabet: search, cloud and AI spending

Alphabet (NASDAQ:GOOGL), Google’s parent company, has continued to build AI into its search business while growing advertising revenue. That adaptability is central to Beauchamp’s view that the company can respond to the technology reshaping its industry.

There are signs of volatility, though. Alphabet’s shares fell 12.6% on 29 October after results showed slower growth in Search revenue. That episode illustrates how quickly investors can reassess expectations when a major business line loses momentum.

The company also has Google Cloud, which can benefit as businesses spend on computing infrastructure and AI. Beauchamp cites Alphabet’s cash generation, profits and balance sheet as resources that could support continued investment. The scale of its business gives it several sources of revenue, but investors still need to weigh those strengths against questions about growth, competition and the costs of AI development.

AstraZeneca: a broad portfolio and research pipeline

AstraZeneca (LON:AZN) stands out to Beauchamp for its existing medicines, research capabilities and pipeline of potential treatments. Its work spans oncology, cardiovascular disease and rare diseases, giving the company opportunities across several areas rather than tying its prospects to one medicine.

The company’s recent $2 billion investment in Summit Therapeutics is another part of that picture. Beauchamp describes the arrangement as a minority stake and clinical collaboration focused on a potential cancer treatment. That structure gives AstraZeneca exposure to the treatment’s development without committing to an outright acquisition, though it does not remove the uncertainty involved in developing new medicines.

The investment sits alongside AstraZeneca’s established commercial portfolio. For investors considering the company, the potential for growth from new treatments comes with the usual uncertainty around research and development, including whether candidates will advance successfully.

Four forces shaping the market outlook

AI: growth expectations meet rising costs

AI has driven heavy spending on data centres and semiconductors. Investors are weighing the possibility that this investment could support future earnings and economic growth against the risk that companies spend too much before the returns arrive. There are also concerns about how AI could affect employment.

Those competing expectations have contributed to swings in technology shares. Higher borrowing costs, greater competition and questions about high valuations can all unsettle investors, even as many AI-related shares have moved higher. The tech-heavy Nasdaq 100 was up 10.7% in 2026 through 13 November, according to the figures cited in Beauchamp’s market assessment.

Oil: a cost that reaches beyond energy companies

Oil prices can affect household bills and business expenses, then feed into inflation, interest-rate decisions and bond yields. Beauchamp says Brent crude was hovering above $90 a barrel amid disruption and uncertainty affecting energy supplies and shipping through the Strait of Hormuz.

For investors, the concern is how long elevated prices persist. A prolonged period of expensive energy can squeeze company margins and household budgets, while sharp changes in supply can make the outlook harder to judge.

Inflation: pressure on costs and share valuations

Higher energy prices have added to costs for households and businesses. Although inflation has eased from its peaks in many economies, Beauchamp says it remains persistent. When inflation rises, central banks may increase interest rates to cool demand. Higher rates can make borrowing more expensive and put pressure on share prices.

The International Monetary Fund expects global headline inflation to reach 4.7% this year, largely reflecting higher commodity prices, before falling to 4.1% next year. Those are global forecasts; inflation can differ considerably between countries.

Earnings: the support that still needs watching

Despite concerns about energy and inflation, company earnings growth in the US and elsewhere remains strong. Beauchamp says solid margins have supported high profit levels, which can help steady share prices when investors become uneasy.

The open question is whether companies can maintain those margins and earnings if costs keep rising. For anyone weighing shares for the rest of 2026 or into 2027, the practical takeaway is to look at each company’s ability to generate cash and sustain its business, while keeping an eye on the market forces that could change the outlook.

Source: [email protected] (Laura Miller) · moneyweek.com

Same key